Clonal Evolution and Heterogeneity of Osimertinib Acquired Resistance Mechanisms in EGFR Mutant Lung Cancer
Nitin Roper(Center for Cancer Research), Udayan Guha(Beltsville Agricultural Research Center), Naris Nilubol(National Institutes of Health), Abhilash Venugopalan(National Cancer Institute), Stephen M. Hewitt(National Institutes of Health), Elizabeth Akoth(Center for Cancer Research), Javed Khan(Alzheimer’s Disease Neuroimaging Initiative), Svetlana Pack(National Cancer Institute), Dee Dee Smart(Center for Cancer Research), Mark Raffeld(National Cancer Institute), Emerson Padiernos(Center for Cancer Research), Liqiang Xi(Center for Cancer Research), Anna‐Leigh Brown(Queen Mary University of London), Zoë Weaver Ohler(Center for Cancer Research), Jun S. Wei(Center for Cancer Research), Tapan K. Maity(Center for Cancer Research), Anna R. Panchenko(Ontario Institute for Cancer Research), Farid Rashidi Mehrabadi(Center for Cancer Research), Zofia Piotrowska(Global Cancer Institute), Constance M. Cultraro(Center for Cancer Research), Aparna H. Kesarwala(Emory Healthcare), Rajaâ El Meskini(Center for Cancer Research), Arun Rajan(National Cancer Institute), Chuong D. Hoang(National Institutes of Health), Christopher Trindade(Center for Cancer Research), Chul Kim(Georgetown University), Haobin Chen(Washington University in St. Louis), S. Cenk Şahinalp(National Institutes of Health), Olivia Restifo(Georgetown University), Shaojian Gao(Center for Cancer Research), Sivasish Sindiri(National Institutes of Health)
Cited by 186
Related Papers
PSORTb 3.0: improved protein subcellular localization prediction with refined localization subcategories and predictive capabilities for all prokaryotes
|Bioinformatics|2010|2.6k
<i>EGFR</i> Mutations and <i>ALK</i> Rearrangements Are Associated with Low Response Rates to PD-1 Pathway Blockade in Non–Small Cell Lung Cancer: A Retrospective Analysis
|Clinical Cancer Research|2016|1.2k
Targeting Tumor-Infiltrating Macrophages Decreases Tumor-Initiating Cells, Relieves Immunosuppression, and Improves Chemotherapeutic Responses
|Cancer Research|2012|941
Rociletinib in <i>EGFR</i>-Mutated Non–Small-Cell Lung Cancer
|New England Journal of Medicine|2015|664